Rhythm Pharmaceuticals Inc
(NAS:RYTM)
$
55.59
-0.95 (-1.68%)
Market Cap: 3.47 Bil
Enterprise Value: 3.14 Bil
PE Ratio: 0
PB Ratio: 308.96
GF Score: 58/100 Rhythm Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) Transcript
Apr 17, 2023 / 07:00PM GMT
Release Date Price:
$20.45
(+5.41%)
Joey Stringer
Needham & Company - Analyst
Good afternoon, everyone. Thank you for joining the 22nd Annual Needham Healthcare Conference. My name is Joey Stringer and I'm one of the biotech analysts at Needham & Company. It's my pleasure to introduce our next presenting company, Rhythm Pharmaceuticals.
Joining us today from Rhythm is President and CEO, David Meeker. For those of you joining on the webcast, if you want to ask a question, you can do so at any time. You can submit a question using the chat box feature at the bottom of your screen. So with that, we'll go ahead and get started.
Questions & Answers
Joey Stringer
Needham & Company - Analyst
David, thank you so much for joining us today.
David Meeker
Rhythm Pharmaceuticals, Inc. - President & CEO
Thank you, Joey. Pleasure to be here.
Joey Stringer
Needham & Company - Analyst
Well, we'll start off with the IMCIVREE launch. We'll get right into it. How would you [handicap
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot